Antitumor activity of nivolumab in recurrent and metastatic nasopharyngeal carcinoma: an international, multicenter study of the Mayo Clinic Phase 2 Consortium (NCI-9742) - Ma, B BY; Lim, W T; Goh, B C (J Clin Oncol, 2018)